Results 201 to 210 of about 103,562 (296)

Not All GLP‐1 Receptor Agonists Are Alike: Real‐World Evidence of Differential Endocrine and Dermatologic Safety

Diabetes/Metabolism Research and Reviews, Volume 42, Issue 4, May 2026.
ABSTRACT Aims Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are widely used for metabolic disorders, but emerging safety concerns include alopecia and reproductive or endocrine‐related adverse events (AEs). This study investigated the association between specific GLP‐1 RAs and these endocrine‐related AEs using a large‐scale pharmacovigilance ...
Nai Lee, Yun Kim
wiley   +1 more source

Glycolysis in polycystic ovary syndrome: pathogenesis and treatment. [PDF]

J Ovarian Res
Xing L, Shi M, Wang Z, Gao H, Li D, Guo R, Zhou X, Chen Y, Xu J, Liang Z, Li T, Zhang K, Shi H, Wang J, Wang R, Zhao R.   +15 more
europepmc   +1 more source

Intersecting Molecular Pathways in Cardiovascular Disease and Diabetes Mellitus: Emerging Roles of Inflammation and Therapeutics

Diabetes/Metabolism Research and Reviews, Volume 42, Issue 4, May 2026.
Central illustration: Pathophysiological mechanisms linking diabetes mellitus and cardiovascular disease. Chronic hyperglycaemia, insulin resistance, and low‐grade inflammation contribute to endothelial dysfunction, myocardial fibrosis, and cardiomyocyte apoptosis.
Lilian Anagnostopoulou, Nikolaos Ktenopoulos, Anastasios Apostolos, Christos Fragoulis, Panayotis Vlachakis, Paschalis Karakasis, Marios Sagris, Nikias Milaras, Maria Drakopoulou, Andreas Synetos, Ioannis Kyriazis, Ioannis Ioannidis, Costas Tsioufis, Konstantinos Toutouzas   +13 more
wiley   +1 more source

Regulatory risk loci link disrupted androgen response to the pathophysiology of polycystic ovary syndrome. [PDF]

J Endocr Soc
Srivastava J, Ovcharenko I.
europepmc   +1 more source

Gut Dysbiosis as a Shared Mechanism in Obesity and Hypertension: Exploring a Promising Therapeutic Avenue

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
This review synthesises current knowledge on gut microbiome involvement in obesity and hypertension, evaluates microbiome‐based therapeutic strategies, and identifies critical research gaps to guide future investigations aimed at mitigating the dual pandemics.
Andrej Belančić, Almir Fajkić, Yusuf Ziya Sener, Ana Jelaković, Lejla Alić, Elvira Meni Maria Gkrinia, Donatella Verbanac, Bojan Jelaković   +7 more
wiley   +1 more source

Prevalence of polycystic ovary syndrome and determinants of knowledge among women in the eastern province Saudi Arabia. [PDF]

Front Reprod Health
Al Shawan D, Alsaad M, Alhumaid B, Shabib F, Almulla S, AlThukair D, Alfawwaz H.   +6 more
europepmc   +1 more source

The Role of Demographic Factors, Clinical Characteristics and Perceived Social Support on the Body Image of Iranian Women With Polycystic Ovary Syndrome: A Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims Women with Polycystic Ovary Syndrome (PCOS) face several physical and psychological challenges, including body image concerns. Factors such as social support, demographic characteristics, and clinical symptoms may influence body image satisfaction in these women.
Roghayeh Arbabi Moghaddam, Seyedeh Batool Hasanpoor–Azghady, Maryam Fasanghari   +2 more
wiley   +1 more source

The Association Between Vitamin D and Polycystic Ovary Syndrome (PCOS) in Women: A Systematic Review. [PDF]

Nutrients
Jaafar B, Chami N, Tlais M, Matar M, Obeid N, Taha N, El Haddad K, Abou Chaaya J, Azar S.   +8 more
europepmc   +1 more source

Investigating the Association Between Serum 25‐Hydroxyvitamin D (25(OH)D) and Body Mass Index (BMI) With In Vitro Fertilization (IVF) Outcomes Among Iranian Women: A Case‐Control Study

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims Infertility affects approximately 18.3% of couples in Iran, and in vitro fertilization (IVF) remains a widely used treatment. Vitamin D deficiency and elevated body mass index (BMI) have been linked to poorer reproductive outcomes in some populations, but region‐specific evidence among Iranian women is limited.
Atefeh Asgari, Reza Mohammadi, Mohaddeseh Kalhori, Salman Khazaei, Azita Tiznobaik   +4 more
wiley   +1 more source